Rheumatology · Pathway 65
Methotrexate
Key points
- Methotrexate is an antimetabolite that inhibits dihydrofolate reductase, an enzyme essential for the synthesis of purines and pyrimidines.
- inflammatory arthritis, especially rheumatoid arthritis
- some chemotherapy acute lymphoblastic leukaemia Adverse effects
- myelosuppression
- pulmonary fibrosis